IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (7)
Cantor Fitzgerald
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 | Bionomics Limit | Health-Care | 12.4 | 1 | WB | CNTR | 11.3% | 19.3% | |||
Dec 3 | Bioplus Acquisi | Finance | 10 | 20 | CNTR | 71.4% | 0.1% | ||||
Oct 14 | Lucid Diagnosti | Health-Care | 14 | 5 | CNTR | CNCD | 100.3% | -16% | |||
Oct 7 | THESEUS Pharmac | Health-Care | 16 | 10 | JEFF | SVB | CNTR | 38.9% | 16.1% | ||
Jul 30 | Rani Therapeuti | Health-Care | 11 | 6 | BAML | Stifel | CNTR | 14.6% | 0% | ||
Jul 2 | NYXOAH SA | Health-Care | 30 | 2 | PS | Stifel | CNTR | 6.4% | 0.4% | ||
Feb 12 | NexImmune Inc. | Health-Care | 17 | 6 | BRCL | CNTR | RAYJ | 53.5% | 49% |
*
Lead manager or one of top three managers in an underwriting team.